Image

Assessing Uterine Cancer Risk in Lynch Syndrome Carriers Using Vaginal Self-sampling and a Health Questionnaire

Assessing Uterine Cancer Risk in Lynch Syndrome Carriers Using Vaginal Self-sampling and a Health Questionnaire

Recruiting
30 years and older
Female
Phase N/A

Powered by AI

Overview

The goal of this study is to find out if self-collected vaginal swabs can be used to detect early signs of uterine cancer or related conditions in people with Lynch syndrome (LS) who still have their uterus. The study also tests if people with LS are willing and able to collect these samples themselves and whether they find the process acceptable.

The main questions this study asks are:

  • Will people with LS take part in self-collection of vaginal samples, and do they find it acceptable?
  • Can vaginal DNA mutations predict cancer risk or match results from other genetic or biopsy testing?
  • Can a cancer risk model used in the general population also help identify risk in people with LS?

Participants will:

  • Answer a health questionnaire about lifestyle and symptoms
  • Collect their own vaginal swabs and measure their vaginal pH at home using a self-collection kit
  • Complete short surveys around the time of self-collection and at the end of the study

Eligibility

Inclusion Criteria:

  • Diagnosed with Lynch syndrome (confirmed by genetic testing).
  • Have an intact uterus.
  • Age 30 years or older.

Exclusion Criteria:

  • History of endometrial cancer or endometrial hyperplasia.
  • History of pelvic radiation or endometrial ablation.
  • Pregnant at the time of study enrolment or during the study.

Study details
    Endometrial Cancer
    Lynch Syndrome

NCT07194551

University of British Columbia

15 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.